Taken together, in the present study, we established an IRRS prognostic model, composed of VEGFA, SOCS3, SPP1, and TGFB2 core DE IRGs, for risk stratification and survival prediction for glioma patients. This evidence concerns the gene TGFB2 and central nervous system cancer.